Kidney health may change how this drug works

NCT ID NCT05936138

Completed Knowledge-focused Sponsor: Eli Lilly and Company Source: ClinicalTrials.gov ↗

First seen Jun 10, 2026 · Last updated Jun 17, 2026 · Updated 3 times

Summary

This study looked at how the drug LY3502970 behaves in people with healthy kidneys compared to those with kidney problems. Researchers measured how much drug gets into the blood and how fast the body clears it. The goal is to understand if kidney impairment changes drug levels, which can help guide proper dosing. 24 adults took part in this single-dose study.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Advanced Pharma CR, LLC

Miami, Florida, 33147, United States
Alliance For multispecialty Research, LLC

Knoxville, Tennessee, 37920, United States
Clinical Pharmacology of Miami

Miami, Florida, 33014, United States
Orlando Clinical Research Center

Orlando, Florida, 32809, United States

Conditions

The condition(s) this trial relates to.

impaired renal function disease kidney failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY RENAL INSUFFICIENCY